Clinical Trial Update: Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether upadacitinib affects the frequency of acute recurrent anterior uveitis in patients with axial spondyloarthritis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: CARE ARTHRITIS LTD. | Conditions: Axial Spondylarthritis (axSpA) | Phase 4 | Status: NOT_YET_RECRUITING